✦ LIBER ✦

Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study

✍ Scribed by Ya-Hsu Yang, Jen-Kou Lin, Wei-Shone Chen, Tzu-Chen Lin, Shung-Haur Yang, Jeng-Kai Jiang, Shih-Ching Chang, Yuan-Tzu Lan, Chun-Chi Lin, Chueh-Chuan Yen, Cheng-Hwai Tzeng, Wei-Shu Wang, Huey-Ling Chiang, Chung-Jen Teng, Hao-Wei Teng

Book ID: 113046650
Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 137 KB
Volume: 20
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-011-1237-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A descriptive study of persistent oxalip

A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer

✍ Vatandoust, Sina; Joshi, Rohit; Pittman, Kenneth B.; Esterman, Adrian; Broadbrid 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 148 KB

Prevention of peripheral sensory neuropa

Prevention of peripheral sensory neuropathy (PSN) by carbamazepine in patients with advanced colorectal cancers (ACRC) treated with oxaliplatin. A pilot study

✍ Lersch, Christian; Eckel, Florian; Assmann, Gerald; Adelsberger, Helmut; Quastho 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Efficacy and safety of tolrestat in the

Efficacy and safety of tolrestat in the treatment of patients with peripheral sensorimotor diabetic neuropathy: an open-label, uncontrolled, pilot study

✍ Rogelio Espinoza Lopez; Jorge Suarez; Marco Antonio Cruz Padron; Jesus Diaz Torr 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 954 KB

The reduced form of coenzyme Q10 improve

The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study

✍ Morito Mezawa; Minoru Takemoto; Shunichiro Onishi; Ryoichi Ishibashi; Takahiro I 📂 Article 📅 2012 🏛 IOS Press 🌐 English ⚖ 88 KB

Leucovorin, fluorouracil, and oxaliplati

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

✍ Yamada, Yasuhide; Takahari, Daisuke; Matsumoto, Hiroshi; Baba, Hideo; Nakamura, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 438 KB

An open-label study of the safety and to

An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer

✍ Brady, Joanne; Corrie, Pippa; Chau, Ian; Digumarti, Raghunadharao; Adams, Laurel 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 164 KB